Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gly-low Supplement Cocktail for Obesity and Aging
NCT05083546Phase 2Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Change in Body Mass Index at 1 year, Change in Frailty at 1 year and 1 more. Planned start Dec 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT05083546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05083546.